Europe & Central Asia vs Norway: Survival to age 65, male
Europe & Central Asia
78.7%
in 2024
Norway
91.1%
in 2024
Europe & Central Asia rank
9th
Norway rank
12th
Survival to age 65, male over time
- Europe & Central Asia
- Norway
How they compare
Norway currently reports 91.1% against 78.7% in Europe & Central Asia, a difference of 12.4%.
That makes Norway's figure about 1.2 times Europe & Central Asia's.
Across all 65 years both countries report, Norway has been ahead every year.
Europe & Central Asia ranks 9th and Norway ranks 12th of 47 groups.
Norway has averaged higher in every one of the 7 decades both report.
Head to head by decade
| Decade | Europe & Central Asia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 64.2% | 74.9% | 10.7% | Norway |
| 1970s | 64.5% | 75.5% | 11.0% | Norway |
| 1980s | 66.5% | 77.4% | 10.9% | Norway |
| 1990s | 66.6% | 81.6% | 15.0% | Norway |
| 2000s | 69.5% | 85.7% | 16.1% | Norway |
| 2010s | 75.8% | 88.9% | 13.2% | Norway |
| 2020s | 77.4% | 90.8% | 13.4% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, male, Europe & Central Asia or Norway?
- Norway, at 91.1% against 78.7% in Europe & Central Asia as of 2024.
- What is the difference in survival to age 65, male between Europe & Central Asia and Norway?
- 12.4%, with Norway ahead.
- How many years of comparable data are there for Europe & Central Asia and Norway?
- 65 years are reported by both, from 1960 to 2024.
- How do Europe & Central Asia and Norway rank globally for survival to age 65, male?
- Europe & Central Asia ranks 9th and Norway ranks 12th of 47 groups.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, male (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.